BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Incara Pharmaceuticals Corporation 

5251 DTC Parkway

Greenwood Village  Colorado  80111  U.S.A.
Phone: 303-804-5655 Fax: 303-804-5661


SEARCH JOBS




Industry
Biotechnology






 Company News
James D. Crapo, M.D. Named CEO Of Incara Pharmaceuticals Corp. (INCR) 10/19/2005 5:11:42 PM    More...
Incara Pharmaceuticals Corp. (INCR) Announces Adjustment To Phase 1 Clinical Trial Of AEOL 10150 To Initiate Safety Studies Directly In Patients With ALS 10/19/2005 5:11:40 PM    More...
Incara Pharmaceuticals Corp. (INCR) Announces Results For Second Quarter Of Fiscal 2004 10/19/2005 5:11:18 PM    More...
Incara Pharmaceuticals Corp. (INCR) To Present At The Rodman & Renshaw Techvest Global Healthcare Conference 10/19/2005 5:11:16 PM    More...
Incara Pharmaceuticals Corp. (INCR) Submits IND To The FDA To Initiate Human Clinical Trials For Novel Therapeutic Approach For ALS; Announces The Resignation Of Its CEO; And Announces Appointment Of Dr. Shayne Gad As President 10/19/2005 5:11:12 PM    More...
Incara Pharmaceuticals Corp. (INCR) Begins Transition To Clinical Development Phase Of Lead Molecule For ALS And Ushers In New Board Of Directors To Manage Transition 10/19/2005 5:11:09 PM    More...
Incara Pharmaceuticals Corp. (INCR) Compound Results Presented At American Academy of Neurology Annual Meeting - Update On Clinical Trials 10/19/2005 5:11:03 PM    More...
Incara Pharmaceuticals Corp. (INCR) Closes On $10.26 Million Financing 10/19/2005 5:10:57 PM    More...
Incara Pharmaceuticals Corp. (INCR) Stockholders Approve Critical Reorganization 10/19/2005 5:10:49 PM    More...
Incara Pharmaceuticals Corp. (INCR) Compound Results To Be Presented At 14th International Symposium On ALS/MND 10/19/2005 5:10:48 PM    More...
123